Not Yet Recruiting
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
NCT05623501
- Conditions
- Alcohol-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +1 more
- Locations
-
- University of Southern California Los Angeles, California, United States